Dr. Pardi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Summary
- Dr. Darrell Pardi is the Chair of the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, MN. He received his medical degree from University of Rochester School of Medicine and Dentistry and has been in practice 25 years. He specializes in inflammatory bowel disease and C. difficile infection and is experienced in general gastroenterology, inflammatory bowel disease, ulcerative colitis, crohn's disease, and microscopic colitis.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 1995 - 1998
University of RochesterResidency, Internal Medicine, 1991 - 1995
University of Rochester School of Medicine and DentistryClass of 1991
Certifications & Licensure
AZ State Medical License 1995 - 2026
FL State Medical License 2019 - 2026
MN State Medical License 1997 - 2025
NY State Medical License 1993 - 1996- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease Start of enrollment: 2006 Jul 20
- SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
- Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis Start of enrollment: 2015 May 01
- Join now to see all
Publications & Presentations
PubMed
- Psychiatric Disorders Among 5,800 Patients With Microscopic Colitis: A Nationwide Population-Based Matched Cohort Study.David Bergman, Bjorn Roelstraete, Jiangwei Sun, Fahim Ebrahimi, Agnieszka Butwicka
The American Journal of Gastroenterology. 2024-12-01 - Quality of bowel preparation for colonoscopy in patients on glucagon-like peptide-1 receptor agonists.Khushboo Gala, June Tome, Mary Krall, Devin Tian, John B League
Gastrointestinal Endoscopy. 2024-11-16 - 1 citationsSafety and Tolerability of CP101, a Full-Spectrum, Oral Microbiome Therapeutic for the Prevention of Recurrent Clostridioides difficile Infection: A Phase 2 Randomized...Jessica R Allegretti, Colleen R Kelly, Thomas Louie, Monika Fischer, Susy Hota
Gastroenterology. 2024-10-02
Journal Articles
- Colon Surgery Risk with Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients with Clostridium Difficile InfectionDipesh Solanky, Sahil Khanna, Darrell S Pardi, Inflammatory Bowel Diseases
Press Mentions
Annual Scientific Meeting & Postgraduate CourseOctober 11th, 2024- PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMIDApril 17th, 2023
- Artificial Intelligence Is Forging a New Future for GastroenterologyFebruary 3rd, 2023
- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Crohn's and Colitis Foundation of AmericaMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
